Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Randomized Controlled Trial Comparing the Axillary Reverse Mapping (ARM) Technique to Standard Axillary Surgery in Breast Cancer Patients.

NCT03109522 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03109522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03109522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Randomized Controlled Trial Comparing the Axillary Reverse Mapping (ARM) Technique to Standard Axillary Surgery in Breast Cancer Patients.
Lead sponsor
McMaster University
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2016
Completion date
September 30, 2020
Enrollment
130 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ductal carcinoma in situ of the breast, invasive breast cancer